Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Independent Task Force to Downstage Oral Cancer Set up - The Pharma Times | Pharma & Health Care News Portal

Independent Task Force to Downstage Oral Cancer Set up

~First-of-its-kind Independent Oral Cancer Task Force in India~ 

Bengaluru, February 07, 2018: On the occasion of World Cancer Day, 4 February 2018, an Independent Oral Cancer Task Force has been launched to develop a strategy for oral cancer control in India over the next decade. This multidisciplinary task force comprises leading specialists who will contribute their expertise to address the burden of oral cancer. The mission of the task force will be to ideate, educate and engage stakeholders, thereby effectively down-staging oral cancer in India. The expected outcome would be to develop a national, cost-effective, patient-centric and sustainable oral cancer control program.

The Oral Cancer Task Force will

  • create a master plan leveraging technology and partnerships
  • develop a framework for operational control and impact measurement
  • establish relevant benchmarks and reference points through primary and secondary research
  • synchronize oral cancer control efforts with the broader national cancer control program
  • enhance and update skills of healthcare professionals
  • establish an environment that reduces the risk factors (tobacco, alcohol, areca nut, HPV) through policy change and public awareness
  • strengthen the National Cancer Registry and surveillance systems
  • map tertiary centers and provide linkages to care.

The independent Oral Cancer Task Force includes recognized experts in their respective fields.

Dr Kiran Mazumdar-Shaw, Founder & Managing Trustee, Biocon Foundation

Dr G K Rath, Chief, Dr. B R Ambedkar Institute Rotary Cancer Hospital, Professor of Radiation Oncology & Head, National Cancer Institute, AIIMS,  Delhi

Dr Pankaj Chaturvedi, Professor and Head & Neck Cancer Surgeon,Tata Memorial Hospital, Mumbai

Dr Kumar Prabhash, Professor, Medical Oncologist, Tata Memorial Hospital, Mumbai

Dr Vijay Chandru, Chairman, Strand Life Sciences, Bengaluru

Dr Moni Abraham Kuriakose, Director, Cochin Cancer Research Centre

Dr Praveen Birur N, Professor & Head of Oral Medicine and Radiology, KLESInstitute of Dental Sciences, Bengaluru, Lead – Oral Cancer Program, Biocon Foundation Oral cancer which is the most common cancer in India amongst men (11.3% of all cancers) and the third most frequently occurring cancer in India amongst both men and women, has seen high incidence of mortality and morbidity that is preventable. Most often, oral cancer is preceded by visually detectable, oral potentially malignant disorders, which present a unique opportunity for the early detection of lesions. Hence it is vital to strengthen the strategies to down-stage oral cancer.

Speaking on the occasion Dr Kiran Mazumdar-Shaw, Founder & Managing Trustee, Biocon Foundation and Convenor of the Oral Cancer Task Force said, “Treatment of oral cancer is a multidisciplinary approach, involving the efforts of dental practitioners, surgeons, medical and radiation oncologists and researchers. The task force that we have established reflects this multidisciplinary requirement. We have therefore come together as a group of independent professionals to constitute a task force to ideate, educate and engage stakeholders, in order to effectively down-stage oral cancer in the next decade.”

Emphasizing the need fortheTask Force,Dr. G K Rath, Head, National Cancer Institute, AIIMS said,“Mortality and morbidity of oral cancer is very high in view of presentation at an advanced stage but this is largely a preventable disease. National Cancer Institute India has been created for this purpose as a centre of national importance which will conduct research into all aspects including prevention, early diagnosis and management. This is the largest single healthcare project of India.”

Dr Pankaj Chaturvedi, Professor and Head & Neck Cancer Surgeon, Tata Memorial Hospital, Mumbai said,“Oral cancer is the most common cause of cancer-related death among Indian men. It is not only an unnecessary human loss but also a huge loss of productivity for India. It is time to wipe out the stigma of India being the oral cancer capital of the world”.

“Oral cancer is primarily related to the use of tobacco which is very common in India. The best way to prevent oral cancer is to stop tobacco use completely. Through this task force, weaim tocreate awareness and work on ways to prevent and enableearly detection of cancer.” said Dr. Kumar Prabhash, Medical Oncologist, Tata Memorial Hospital. 

The Guest of Honour,Dr K B Linge Gowda, Director, Kidwai Memorial Institute of Oncology, commended the efforts of the task force to down-stage oral cancer in India.

For information contact 

Biocon Foundation:

PratimaRao:  info.bioconfoundation@biocon.com

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

4 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

6 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago